secwatch.observer — SEC 8-K summary
======================================

Issuer:     Seer, Inc. (SEER)
CIK:        0001726445
Form:       8-K
Filed at:   2025-07-08T23:59:59+00:00
Accession:  0000950170-25-094597
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Seer non-compliant with Nasdaq Audit Committee rule after annual meeting; cure period sought
--------------------------------------------------------------------------------

- On July 7, 2025, notified Nasdaq that post-annual meeting it will not comply with Rule 5605(c)(2)(A) requiring at least three Audit Committee members, one with financial sophistication.
- Intends to rely on cure period under Rule 5605(c)(4)(B) and expects to regain compliance before expiration.
- Annual meeting elected all six director nominees: Farokhzad, Gulyani, McGuire, Langer, Nishar, Roelofs (withheld votes ranged from 0.6M to 10.0M).
- Stockholders ratified Deloitte & Touche as independent auditor for FY2025 with 85.9M votes for, 4,444 against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1726445/000095017025094597/0000950170-25-094597-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1726445/000095017025094597/ck0001726445-20250707.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-094597

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer